Skip to content

Family Intervention for Obese Children Using Portion Control Strategy for Weight Control

Family Intervention for Obese Children Using Portion Control Strategy (F.O.C.U.S.) for Weight Control- A Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00881478
Acronym
FOCUS
Enrollment
102
Registered
2009-04-15
Start date
2009-08-31
Completion date
2014-08-31
Last updated
2014-09-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Keywords

Obesity, Children, Dyslipidemia, Hypertension

Brief summary

Obesity in children is a serious disease that is associated with increased mortality and decreased life expectancy. A simple tool used to assist in controlling portions (and therefore calorie intake) at mealtime would be of benefit in promoting weight maintenance and/or loss. The purpose of this study is to assess the efficacy of a family intervention using a portion control tool to help control weight in obese children. The investigators hypothesize that the use of portion control tools by the parents and child will result in a greater decrease in the child's BMI over a 6 month period compared with the control group.

Detailed description

This study is a randomized controlled trial designed to assess the efficacy of a portion control tool to help improve body mass index in obese children over a 6 months period. This study will also assess whether this weight control strategy results in improvement of blood pressure, waist circumference, and biomarkers of obesity including plasma visfatin, adiponectin, fasting lipid profile and apolipoprotein B, liver function tests and fasting insulin and glucose. Both the intervention and the control group will receive a one hour session of standard dietary counseling from a registered dietician at baseline regarding healthy eating habits, appropriate portion sizes and the Canada Food Guide. The duration of this study will be 6 months. Baseline measurements will be taken at the initial visit and again at 3 months and 6 months. Each participants' height and weight will be measured, and BMI will be calculated. Waist circumference and blood pressure will also be measured. A blood sample will be drawn at baseline and 6 months for a fasting lipid profile, fasting insulin, and glucose levels. Measurement of plasma visfatin and adiponectin levels using ELISA will be carried out.

Interventions

OTHERNutrition counseling + portion control tool

Nutrition counseling with registered dietician in addition to teaching about how use of a portion control tool

OTHERNutrition counseling

Nutrition counseling with registered dietician

Sponsors

University of Calgary
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
8 Years to 16 Years
Healthy volunteers
Yes

Inclusion criteria

* age 8 years old to 16 years old * BMI greater than or equal to the 85th percentile for age and gender

Exclusion criteria

* patients currently taking a weight loss medication * gastrointestinal disorder * psychiatric illness under the care of a psychiatrist * Cushing's syndrome * hypothalamic or genetic etiology of obesity * uncontrolled or untreated thyroid disease * current diagnosis of cancer * history of an eating disorder such as bulimia or anorexia nervosa * surgery in the past 3 months * surgery planned in the ensuing 6 months * any chronic illness that could affect weight status

Design outcomes

Primary

MeasureTime frame
Change in age and gender adjusted BMI z-score6 months

Secondary

MeasureTime frame
Change in age and gender adjusted blood pressure percentile6 months
Change in fasting lipid profile6 months
Change in fasting insulin and fasting glucose6 months
Change in age and gender adjusted waist circumference percentile6 months
Change in plasma adiponectin level6 months
Proportion of children achieving a BMI below the 85th percentile for age and gender6 months
Change in plasma visfatin level6 months

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026